21.95
Precedente Chiudi:
$22.25
Aprire:
$22.25
Volume 24 ore:
366.08K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.13B
Reddito:
$412.82M
Utile/perdita netta:
$-8.19M
Rapporto P/E:
-142.44
EPS:
-0.1541
Flusso di cassa netto:
$64.17M
1 W Prestazione:
-3.73%
1M Prestazione:
+0.60%
6M Prestazione:
+16.14%
1 anno Prestazione:
+12.45%
Caredx Inc Stock (CDNA) Company Profile
Nome
Caredx Inc
Settore
Industria
Telefono
415-287-2300
Indirizzo
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CDNA
Caredx Inc
|
21.95 | 1.15B | 412.82M | -8.19M | 64.17M | -0.1541 |
|
TMO
Thermo Fisher Scientific Inc
|
469.63 | 175.70B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
183.53 | 130.44B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
561.17 | 44.34B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
132.69 | 38.25B | 7.23B | 1.41B | 1.09B | 4.979 |
|
WAT
Waters Corp
|
363.34 | 35.87B | 3.77B | 449.25M | 240.68M | 7.8556 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-08-26 | Iniziato | William Blair | Mkt Perform |
| 2025-01-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Underweight |
| 2024-08-19 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-05-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2023-11-09 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-03-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Downgrade | Craig Hallum | Buy → Hold |
| 2023-03-03 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2021-07-20 | Ripresa | BTIG Research | Buy |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-02-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-08 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-26 | Iniziato | BTIG Research | Buy |
| 2020-06-19 | Reiterato | H.C. Wainwright | Buy |
| 2019-10-01 | Ripresa | Craig Hallum | Buy |
| 2019-05-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Iniziato | Jefferies | Buy |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Neutral |
| 2017-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2016-06-14 | Reiterato | Mizuho | Buy |
| 2015-09-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Iniziato | Craig Hallum | Buy |
| 2015-03-18 | Reiterato | Mizuho | Buy |
Mostra tutto
Caredx Inc Borsa (CDNA) Ultime notizie
CareDx Showcases Strong Q1 Growth and Expanding Pipeline at Jefferies - HarianBasis.co
CareDx (CDNA) Q3 2023 Earnings Call Transcript - MLQ.ai
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies - Yahoo Finance
M3 to Acquire WISEMAN to Boost Healthcare and Nursing Care DX - TipRanks
Insider sale reported for CDNA (NASDAQ: CDNA) under 10b5-1 plan - Stock Titan
CDNA: Q1 revenue up 39%, Naveris acquisition boosts oncology, and pipeline advances in transplant and cancer - TradingView
CareDx Deadline Alert - TMX Newsfile
U.S. Supreme Court rejects CareDx appeal in Natera false-advertising dispute - Reuters
CareDx (CDNA) Supreme Court Appeal Denied, Lower Court Ruling St - GuruFocus
Justices Skip CareDx's Bid To Revive $45M False Ad Award - Law360
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup - ChartMill
The Technical Signals Behind (CDNA) That Institutions Follow - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and CareDx (CDNA) - The Globe and Mail
William Blair Maintains CareDx(CDNA.US) With Hold Rating - Moomoo
28% Of This CareDx Insider's Holdings Were Sold - Moomoo
CDNA Technical Analysis & Stock Price Forecast - Intellectia AI
CareDx Earnings Call: Growth, Navaris Deal and Pivot - The Globe and Mail
CareDx to Participate in Upcoming June 2026 Investor Conferences - BioSpace
CareDx plans June talks at Jefferies and Goldman Sachs healthcare events - Stock Titan
CareDx to Participate in Upcoming Investor Conferences - The Joplin Globe
Precision Trading with Caredx Inc. (CDNA) Risk Zones - Stock Traders Daily
Insider Sell Alert: Arthur Torres Sells Shares of CareDx Inc (CD - GuruFocus
CareDx director Arthur Torres sells $214,675 in company stock By Investing.com - Investing.com Nigeria
CareDx director Arthur Torres sells $214,675 in company stock - Investing.com
CareDx (CDNA) director sells 10,570 shares in open-market trades - Stock Titan
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's CareDx Inc(CDNA) Holding History - GuruFocus
ETFs Investing in CareDx, Inc. Stocks - TradingView
Rule 144 notice and recent sale by insider (CDNA) - Stock Titan
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx expands HeartCare platform to transform post transplant care for heart recipients - Traders Union
How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - Sahm
CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus
Caredx announces dismissal of 2021 qui tam suit - marketscreener.com
CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - marketscreener.com
Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo
The real story behind CareDx (CDNA) earnings numbers | Q1 2026: Better Than ExpectedQuarterly Profit Report - The Legal Advocate
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan
CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance
CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan
How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
MSN Money - MSN
23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan
CareDx sharpens focus on core testing services - MSN
Caredx Inc Azioni (CDNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Caredx Inc Azioni (CDNA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TORRES ARTHUR A | Director |
May 15 '26 |
Sale |
19.89 |
6,484 |
128,978 |
38,665 |
| TORRES ARTHUR A | Director |
May 14 '26 |
Sale |
20.97 |
4,086 |
85,698 |
45,149 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):